Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.
about
Differential role of Hedgehog signaling in human pancreatic (patho-) physiology: An up to date reviewGenetics and biology of pancreatic ductal adenocarcinomaImproving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysisRoles of Commensal Microbiota in Pancreas Homeostasis and Pancreatic PathologiesPancreatic cancer: yesterday, today and tomorrow.Update on our investigation of malignant tumors associated with Peutz-Jeghers syndrome in Japan.Leptin-Notch signaling axis is involved in pancreatic cancer progressionA rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics.Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinoma.MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in QuebecPancreatic cancer serum biomarker PC-594: Diagnostic performance and comparison to CA19-9.Frequency and Significance of Abnormal Pancreatic Imaging in Patients with BRCA1 and BRCA2 Genetic Mutations.Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.Nutrients and the Pancreas: An Epigenetic Perspective.The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer.SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin.A comprehensive analysis of candidate genes and pathways in pancreatic cancer.Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia.Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future Perspectives.Antibody-mediated neutralization of autocrine Gas6 inhibits the growth of pancreatic ductal adenocarcinoma tumors in vivo.Inflammation as a driver and vulnerability of KRAS mediated oncogenesisSelf-Reported Questionnaire Detects Family History of Cancer in a Pancreatic Cancer Screening ProgramGlobal Trends in Pancreatic Cancer Mortality From 1980 Through 2013 and Predictions for 2017.Do founder mutations characteristic of some cancer sites also predispose to pancreatic cancer?Signs and genetics of rare cancer syndromes with gastroenterological features.Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer.Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas.Adiponectin receptor agonists inhibit leptin induced pSTAT3 and in vivo pancreatic tumor growth.Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers.Pancreatic Cancer in Lynch Syndrome Patients.Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel.Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data.A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss of Function Polymorphisms and Indoleamine-2,3-Dioxygenase-2.Pancreatic cancer screening.Evaluation of SAS1B as a target for antibody-drug conjugate therapy in the treatment of pancreatic cancer.LncRNA BC032020 suppresses the survival of human pancreatic ductal adenocarcinoma cells by targeting ZNF451.Pancreatic cancer screening.Pancreatic adenocarcinoma, chronic pancreatitis, and MODY-8 diabetes: is bile salt-dependent lipase (or carboxyl ester lipase) at the crossroads of pancreatic pathologies?PRDM14 is overexpressed in chronic pancreatitis prior to pancreatic cancer
P2860
Q26748692-62992B83-70AD-41CA-968C-3D1335CD7752Q26765438-B1950038-5E18-463A-BB75-83B5F5C4BD50Q26782719-B17F5E72-4F4F-4BB5-9A1B-5809F335B5EDQ26782979-EF6ADDDC-78FF-4C35-85FE-749C96D38772Q30250026-148DB07D-C6E6-4C73-BC4C-214A0A525FDAQ30251978-65D65191-1BD6-4475-A88A-AC98DFC53219Q30396675-73B54230-BDE5-480B-98F2-CE385083B191Q30669159-CE926191-A097-47AC-BFBA-A0674BF1B39BQ33914066-82648956-0C39-4BAB-86B3-8B2F46B41632Q35113043-2BDEF491-42E7-4181-BFA4-BE88A44BC06DQ35444944-2EFFBE7F-3A3D-4470-B935-D39D0BD5125BQ35692287-9C51A5CE-08CD-43CB-B31E-FE8D50A5314EQ36742040-935C2B30-B04B-4631-9BD6-2D25DB20842FQ37687464-9768DB87-AEE9-4551-8056-2DA33405F438Q37729841-3DBB2CAE-5974-4B70-9F15-8A4B8126E2E9Q38404425-97FC2DBF-8A65-4070-B355-3F8063A89198Q38421269-1427B433-6A56-41D6-A5D8-443DDBBC69E6Q38470363-B874B454-A011-4FF1-AE00-A0D08F4CB447Q38652820-7E3BD03D-6D54-43CE-BBD1-9209C4854232Q38768150-009725F5-CD5E-4CAC-BA44-85CC121EB428Q38771601-DE66C09B-9CEA-4426-8E6E-83B7EFDA8223Q38864070-34786543-828F-4175-B0E4-958B2ED783BDQ39048127-E08AB206-1218-49C1-AE53-5B35597F19C0Q39706900-47E67C5A-5351-4C0C-95CF-C57FD5A56C60Q40821559-329254DD-8A28-4C2E-981F-5BA0CB8404C0Q42434480-E46E62DE-895B-4BA6-AE7F-2E457374252EQ45901388-CFA78825-2492-459E-ACF6-ADF2ADC800CFQ46092740-014C57B9-08AF-46F8-B148-1057B5A13087Q47102231-3F96E8C7-EB2E-43C3-B968-0FE86BF0EB9EQ47109220-00B0B1B0-A472-4098-BA7F-F4A495E66696Q47153954-2DB4B617-B0A8-4D5C-B38B-B1543079F0DCQ47154567-1C459914-E9E2-408D-AED4-24130FC0C9F3Q47578665-7D39D6F8-586B-4B81-9EDA-D169114FD6BEQ50095635-CAAEA0FA-00C1-408A-9A87-9B988FC63F98Q50495938-F0012D7E-28C2-4CD7-972E-7BDC826126DEQ52672976-96FB23A3-E240-4253-8D4B-A414C540FC35Q52726920-D12AED41-0F6A-409D-9D62-A43D3CED4100Q54492414-5F3CC397-AB0A-4DBD-923C-8FF82D683A13Q55279308-2D62CD77-779B-41A2-85E5-DCD66165861EQ58554308-DAFF5483-DBBD-460E-B1F6-7A270BABE790
P2860
Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.
@ast
Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.
@en
Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.
@nl
type
label
Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.
@ast
Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.
@en
Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.
@nl
prefLabel
Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.
@ast
Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.
@en
Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.
@nl
P2093
P2860
P1476
Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.
@en
P2093
Aimee L Lucas
Andrew E Becker
Harold Frucht
Yasmin G Hernandez
P2860
P304
11182-11198
P356
10.3748/WJG.V20.I32.11182
P407
P577
2014-08-01T00:00:00Z